Basic Information
| RNALocate ID: | RLID:11003263 |
| RNA Symbol: | hsa-miR-582-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-582-5p |
| RNA ID: | miRBase:MIMAT0003247 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002441 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002442 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002443 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003264 | Exosome | Serum | 25349172 |
| RLID-D:11000518 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
| RLID-D:11001344 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-582-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-61779 |
| MNDR | hsa-miR-582-5p | Medulloblastoma | MNDR-E-MI-61780 |
| MNDR | hsa-miR-582-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-61781 |
| MNDR | hsa-miR-582-5p | Lymphoma | MNDR-E-MI-61782 |
| MNDR | hsa-miR-582-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-61783 |
| MNDR | hsa-miR-582-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-61784 |
| MNDR | hsa-miR-582-5p | Her2-receptor positive breast cancer | MNDR-E-MI-61785 |
| MNDR | hsa-miR-582-5p | Prostate cancer | MNDR-E-MI-61786 |
| MNDR | hsa-miR-582-5p | Gastric cancer | MNDR-E-MI-61787 |
| MNDR | hsa-miR-582-5p | Alzheimer disease | MNDR-E-MI-61788 |
| MNDR | hsa-miR-582-5p | Intracranial aneurysm | MNDR-E-MI-61789 |
| MNDR | hsa-miR-582-5p | Bladder cancer | MNDR-E-MI-61790 |
| MNDR | hsa-miR-582-5p | Esophageal carcinoma | MNDR-E-MI-61791 |
| MNDR | hsa-miR-582-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-61792 |
| MNDR | hsa-miR-582-5p | Leukemia | MNDR-E-MI-61793 |
| MNDR | hsa-miR-582-5p | Cardiovascular disease | MNDR-E-MI-61794 |
| MNDR | hsa-miR-582-5p | Uterine fibroid | MNDR-E-MI-61795 |
| MNDR | hsa-miR-582-5p | Lung cancer | MNDR-E-MI-61796 |
| MNDR | hsa-miR-582-5p | Parkinson disease | MNDR-E-MI-61797 |
| MNDR | hsa-miR-582-5p | Breast cancer | MNDR-E-MI-61798 |
| MNDR | hsa-miR-582-5p | Pituitary neoplasms | MNDR-E-MI-61799 |
| MNDR | hsa-miR-582-5p | Malignant mesothelioma | MNDR-E-MI-61800 |
| MNDR | hsa-miR-582-5p | Pancreatic cancer | MNDR-E-MI-61801 |
| MNDR | hsa-miR-582-5p | Melanoma | MNDR-E-MI-61802 |
| MNDR | hsa-miR-582-5p | Rectum adenocarcinoma | MNDR-E-MI-61803 |
| MNDR | hsa-miR-582-5p | Nephroblastoma | MNDR-E-MI-61804 |
| MNDR | hsa-miR-582-5p | Colon cancer | MNDR-E-MI-61805 |
| MNDR | hsa-miR-582-5p | Colon adenocarcinoma | MNDR-E-MI-61806 |
| MNDR | hsa-miR-582-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-61807 |
| MNDR | hsa-miR-582-5p | Prostate adenocarcinoma | MNDR-E-MI-61808 |
| MNDR | hsa-miR-582-5p | Glioblastoma | MNDR-E-MI-61809 |
| MNDR | hsa-miR-582-5p | Glioma | MNDR-E-MI-61810 |
| MNDR | hsa-miR-582-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-61811 |
| MNDR | hsa-miR-582-5p | Osteosarcoma | MNDR-E-MI-61812 |
| MNDR | hsa-miR-582-5p | Gastric adenocarcinoma | MNDR-E-MI-61813 |
| MNDR | hsa-miR-582-5p | Pituitary adenoma | MNDR-E-MI-61814 |
| MNDR | hsa-miR-582-5p | Lung squamous cell carcinoma | MNDR-E-MI-61815 |
| MNDR | hsa-miR-582-5p | Lung adenocarcinoma | MNDR-E-MI-61816 |
| MNDR | hsa-miR-582-5p | Bladder urothelial carcinoma | MNDR-E-MI-61817 |
| MNDR | hsa-miR-582-5p | Carcinoma renal cell | MNDR-E-MI-61818 |
| MNDR | hsa-miR-582-5p | Cholangiocarcinoma | MNDR-E-MI-61819 |
| MNDR | hsa-miR-582-5p | Hepatocellular carcinoma | MNDR-E-MI-61820 |
| MNDR | hsa-miR-582-5p | B-cell lymphoma | MNDR-E-MI-61821 |
| MNDR | hsa-miR-582-5p | Retinoblastoma | MNDR-E-MI-61822 |
| MNDR | hsa-miR-582-5p | Hodgkin lymphoma | MNDR-E-MI-61823 |
| MNDR | hsa-miR-582-5p | Colorectal cancer | MNDR-E-MI-61824 |
| MNDR | hsa-miR-582-5p | Epstein-barr virus infections | MNDR-E-MI-61825 |
| MNDR | hsa-miR-582-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-61826 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CASP3 | Homo sapiens | RR00278989 |
TOP